Illumina, Inc. - Common Stock (ILMN)

$95.86 0.10 (0.10%)

10:05 EST ILMN Stock Quote Delayed 30 Minutes

7 Stocks Gearing Up for a Major Breakout

By Larry Ramer, InvestorPlace Contributor Mar 31, 2023

With the stock market gearing up for a major breakout, there are many potential breakout stocks at this point.

3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time

ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies

ILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illumina

Volume:

Previous Close -

Market Cap 15.20B

PE Ratio -12.48

EPS -7.68

Volume (Avg. Vol.) 135,820

Day's Range $95.35 - $96.88

52-Week Range $91.92 - $156.66

Dividend & Yield N/A (N/A)

ILMN Stock Predictions, Articles, and Illumina, Inc. - Common Stock News

7 Stocks to Buy and Hold for the Next 20 Years

By Larry Ramer, InvestorPlace Contributor Feb 12, 2023

When choosing stocks to buy and hold for the next 20 years, pick companies with strong comparative advantages in durable sectors.

Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest

By Larry Ramer, InvestorPlace Contributor Oct 28, 2022

Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point.

3 Biotech Stocks to Sell in October

By Muslim Farooque, InvestorPlace Contributor Sep 29, 2022

These biotech stocks to sell are at a cross roads with their businesses with few growth catalysts ahead amid this turbulent market.

The 3 Best Healthcare Stocks to Buy Now

By Larry Ramer, InvestorPlace Contributor Sep 9, 2022

Investors are less worried about the regulation of the U.S. healthcare sector, making this a good time to buy the best healthcare stocks.

Illumina (ILMN) Stock Rises After Its Win Against the FTC

By Josh Enomoto, InvestorPlace Contributor Sep 2, 2022

Illumina just secured a major legal win against the FTC regarding an acquisition, initially sparking a boost in ILMN stock.

Why Is Illumina (ILMN) Stock Plunging 10% Today?

By Shrey Dua, InvestorPlace Senior Financial News Reporter Aug 12, 2022

California-based gene sequencer Illumina is well in the red today after a brutal earnings miss. ILMN stock is down 10% on weak results.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Aug 12, 2022

Good morning! We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!

7 Wildly Oversold S&P 500 Stocks to Buy Now

By Ian Bezek, InvestorPlace Contributor Jul 20, 2022

These seven S&P 500 stocks to buy have crashed amid 2022's market turmoil and are now set for a swift rebound.

3 Biotech Stocks to Sell Now

By Tyler Craig, Tales of a Technician Jul 5, 2022

These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead.

7 Beaten-Down S&P 500 Stocks to Buy Before They Rebound

By Larry Ramer, InvestorPlace Contributor Jun 30, 2022

With the market becoming more convinced that a "soft landing" is in the cards, there are many good, beaten-down S&P 500 stocks to buy.

Forget About the Genomic Revolution, the Proteomic Revolution Is Coming

By Luke Lango, InvestorPlace Senior Investment Analyst Sep 3, 2021

Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.

Forget About the Genomic Revolution, the Proteomic Revolution Is Coming

By Luke Lango, InvestorPlace Senior Investment Analyst Sep 3, 2021

Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.